Dr. Stacy R. Smith , MD
Dermatology • Encinitas, CA
561 Saxony Pl, Suite 102
Encinitas, CA 920247700
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on March 8, 2006; this date does not establish years in practice.
-
Published CMS data list 12 Medicare Part D prescriptions, including refills, in 2018.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2018. Published rows only; this is not a quality measure.
-
Published Part D records, 2018:
- Taltz Autoinjector (Ixekizumab) — 12 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2018. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part D prescriptions went from 13 in 2013 to 12 in 2018.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2013–2018.
Practice Location & Contact Primary Location
561 Saxony Pl
Suite 102
Encinitas, CA 920247700
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
12 standardized 30-day fills in 2018
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$60,360 in 2018
The total cost of these prescriptions in 2018, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2018.
Open Payments general payments, program year 2025
All general payments: $90,861.71 across 38 records.
By nature of payment (3 largest of 4)
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program: $65,100.00 across 28 records.
- Consulting Fee: $23,950.00 across 3 records.
- Travel and Lodging: $1,297.90 across 2 records.
Reporting-company totals (3 largest of 5)
- Eli Lilly and Company: $43,008.16 across 23 records.
- Krystal Biotech Inc: $21,775.00 across 2 records.
- ABBVIE INC.: $16,923.82 across 7 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Encinitas and California
Billing and prescribing volume is not a quality rating.
Medicare Part D
Comparisons use 2024 data. The latest CMS data for Dr. Smith are from 2018.
13 active clinicians are listed under Dermatology with a practice address in Encinitas, CA (2,084 in California).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Encinitas
23.1% of these 13 clinicians have the CMS telehealth indicator.
61.5% of these 13 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions went from 13 in 2013 to 12 in 2018.
- 2013: 13
- 2016: 12
- 2017: 12
- 2018: 12
-
30-day fills
30-day fills went from 13 in 2013 to 12 in 2018.
- 2013: 13
- 2016: 12
- 2017: 12
- 2018: 12
-
Part D drug cost
Part D drug cost increased 103% from $29,769 in 2013 to $60,360 in 2018.
- 2013: $29,769
- 2016: $47,863
- 2017: $55,662
- 2018: $60,360
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 10% from $82,945.33 in 2021 to $90,861.71 in 2025.
- 2021: $82,945.33
- 2022: $304,712.44
- 2023: $235,518.58
- 2024: $129,652.45
- 2025: $90,861.71
Sources: CMS Medicare Part D Prescribers (2018), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 38 records totaling $90,861.71.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Krystal Biotech Inc |
Consulting Fee
Cash or cash equivalent
|
— | General | $20,800.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TREMFYA | General | $4,050.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RINVOQ | General | $3,625.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RINVOQ | General | $3,625.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
SKYRIZI | General | $3,625.00 |
| ABBVIE INC. |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
RINVOQ | General | $3,625.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $3,200.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $3,200.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $3,200.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
OLUMIANT | General | $3,200.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $3,200.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $2,800.00 |
| ABBVIE INC. |
Consulting Fee
Cash or cash equivalent
|
— | General | $2,175.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $2,000.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $2,000.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $2,000.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TREMFYA | General | $1,800.00 |
| Janssen Pharmaceuticals, Inc |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
TREMFYA | General | $1,800.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $1,600.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $1,600.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $1,600.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
OLUMIANT | General | $1,600.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $1,600.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
EBGLYSS | General | $1,600.00 |
| Eli Lilly and Company |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Cash or cash equivalent
|
— | General | $1,600.00 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2018.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Taltz Autoinjector | Ixekizumab | 12 | 330 | $60,360.39 | — |
Source: CMS Part D by Provider and Drug, 2018; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Additional State Medicaid & Healthcare Payer Identifiers
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner
Doctor of Philosophy (Ph.D.), Family Nurse Practitioner
Career & Practice History
NPI enumerated March 08, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to August 2026.
NPI Administrative Meta
Other Dermatology Specialists in Encinitas
- Kathleen O'brien
- Dr. Hannah Berman, MD
- Dr. Lisa Stirling, MD
- Dr. Margaret Dupree, MD
- Dr. Andres Cruz-Inigo, MD
- Elizabeth Cooper
Mailing Address
561 Saxony Pl, Suite 102
Encinitas, CA 920247700
Phone: 7602033839